Literature DB >> 19302050

Regulation and function of NF-kappaB transcription factors in the immune system.

Sivakumar Vallabhapurapu1, Michael Karin.   

Abstract

The mammalian Rel/NF-kappaB family of transcription factors, including RelA, c-Rel, RelB, NF-kappaB1 (p50 and its precursor p105), and NF-kappaB2 (p52 and its precursor p100), plays a central role in the immune system by regulating several processes ranging from the development and survival of lymphocytes and lymphoid organs to the control of immune responses and malignant transformation. The five members of the NF-kappaB family are normally kept inactive in the cytoplasm by interaction with inhibitors called IkappaBs or the unprocessed forms of NF-kappaB1 and NF-kappaB2. A wide variety of signals emanating from antigen receptors, pattern-recognition receptors, receptors for the members of TNF and IL-1 cytokine families, and others induce differential activation of NF-kappaB heterodimers. Although work over the past two decades has shed significant light on the regulation of NF-kappaB transcription factors and their functions, much progress has been made in the past two years revealing new insights into the regulation and functions of NF-kappaB. This recent progress is covered in this review.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302050     DOI: 10.1146/annurev.immunol.021908.132641

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  1057 in total

Review 1.  Selectivity of the NF-{kappa}B response.

Authors:  Ranjan Sen; Stephen T Smale
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-14       Impact factor: 10.005

2.  NF-kappaB inhibits T-cell activation-induced, p73-dependent cell death by induction of MDM2.

Authors:  Valere Busuttil; Nathalie Droin; Laura McCormick; Francesca Bernassola; Eleonora Candi; Gerry Melino; Douglas R Green
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

3.  Loss of c-REL but not NF-κB2 prevents autoimmune disease driven by FasL mutation.

Authors:  L A O'Reilly; P Hughes; A Lin; P Waring; U Siebenlist; R Jain; D H D Gray; S Gerondakis; A Strasser
Journal:  Cell Death Differ       Date:  2014-10-31       Impact factor: 15.828

Review 4.  Novel functions of viral anti-apoptotic factors.

Authors:  Chengyu Liang; Byung-Ha Oh; Jae U Jung
Journal:  Nat Rev Microbiol       Date:  2014-11-03       Impact factor: 60.633

Review 5.  Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.

Authors:  Donald B Jump; Kelli A Lytle; Christopher M Depner; Sasmita Tripathy
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

6.  An immune-stimulating proteoglycan from the medicinal mushroom Huaier up-regulates NF-κB and MAPK signaling via Toll-like receptor 4.

Authors:  Ailin Yang; Haitao Fan; Yanan Zhao; Xiaonan Chen; Zhixiang Zhu; Xiaojun Zha; Yunfang Zhao; Xingyun Chai; Jun Li; Pengfei Tu; Zhongdong Hu
Journal:  J Biol Chem       Date:  2019-01-02       Impact factor: 5.157

7.  Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation.

Authors:  Fuminori Tokunaga; Hiroshi Nishimasu; Ryuichiro Ishitani; Eiji Goto; Takuya Noguchi; Kazuhiro Mio; Kiyoko Kamei; Averil Ma; Kazuhiro Iwai; Osamu Nureki
Journal:  EMBO J       Date:  2012-08-28       Impact factor: 11.598

8.  RhoB regulates the function of macrophages in the hypoxia-induced inflammatory response.

Authors:  Gaoxiang Huang; Jie Su; Mingzhuo Zhang; Yiduo Jin; Yan Wang; Peng Zhou; Jian Lu
Journal:  Cell Mol Immunol       Date:  2015-09-21       Impact factor: 11.530

Review 9.  The physiological roles of placental corticotropin releasing hormone in pregnancy and childbirth.

Authors:  Murray Thomson
Journal:  J Physiol Biochem       Date:  2012-12-29       Impact factor: 4.158

10.  A novel class of lipoprotein lipase-sensitive molecules mediates Toll-like receptor 2 activation by Porphyromonas gingivalis.

Authors:  Sumita Jain; Stephen R Coats; Ana M Chang; Richard P Darveau
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.